Source: Google NewsPublished on 2023-03-16
Related Articles:
- Bayer doubles down on Parkinson’s? December 10, 2020 # # # # News today of two biotech companies merging did not cause much of a ripple in the media, but the wider implications of the move are rather significant for Parkinson’s. Today it was announced that Brain Neurotherapy Bio (BNB) is going to merge with Asklepios Biopharmaceutical (aka AskBio). BNB are currently clinically testing a GDNF gene therapy…
- Coming Soon…the Rune Labs’ Patient Advisory Board February 10, 2022 Back in the good ol’ pre-covid days of 2018, I went to my neurologist, Dr. Alfonso Fasano, with an idea about speaking to the doctors at my clinic about the journey I’d been on as a patient advocate. He loved it and arranged a talk at the Toronto Western Hospital (TWH) for the entire Movement Disorder Clinic (MDC). Among those…
- The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s. It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
- Monthly Research Review – June 2022 June 30, 2022 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during June 2022. The post is divided into 10 parts based on the type of research: Top 7 pieces of Parkinson’s news Articles of general interest Basic biology…
- The Bluerockers have started July 15, 2021 # # # # On the 8th June, BlueRock Therapeutics put out a press release announcing that the first participant in their Phase I clinical trial of cell transplantation for Parkinson’s had been dosed (Click here to read the press release). The initiation of this clinical trial by the company is a major step forward for them and for the…
- The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
- Rune Labs' Apple Watch-based Parkinson's disease tracker gets FDA clearance - The Verge June 13, 2022 Rune Labs' Apple Watch-based Parkinson's disease tracker gets FDA clearance The VergeRune Labs Secures FDA Clearance for Parkinson's Disease Monitoring through StrivePD Ecosystem on Apple Watch BioSpaceStartup gets green light to use Apple Watch to track Parkinson's symptoms STATRune Labs gets FDA clearance to use Apple Watch to track Parkinson's symptoms Reuters.comApple Watch Parkinson's monitoring app gets FDA approval for clinical use 9to5Mac
- Rune Labs' Apple Watch tracking for Parkinson's earns FDA green light - STAT June 13, 2022 Rune Labs' Apple Watch tracking for Parkinson's earns FDA green light STATRune Labs Secures FDA Clearance for Parkinson's Disease Monitoring through StrivePD Ecosystem on Apple Watch PR NewswireApple Watch Parkinson's monitoring app gets FDA approval for clinical use 9to5MacRune Labs gets FDA clearance to use Apple Watch to track Parkinson's symptoms Reuters.comThe Apple Watch Has Been Cleared by the FDA to Monitor Parkinson’s Disease…
- The Team February 1, 2023 Brighton to BarcelonaWith only 141 days to go, it feels like the right time to introduce the Brighton to Barcelona team. We are a group of 21 cyclists plus our guide. We will set off on 16th June this year and cycle an average of 106km each day until reaching Barcelona on 2nd July in time to attend the World…
- Year in review: 2021 December 31, 2021 # # # # As with the preceding year, 2021 proved to be challenging due to the continuing COVID-19 pandemic (and it is not over yet). Vaccines were rolled out with remarkable speed, but equally new variants of the virus popped up and have kept Governments and health regulatory bodies on their toes. An amazing feature of the last two…
- The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…
- 2020: Year in Review January 1, 2021 # # # # In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2020. Month-by-month we will briefly discuss some of the major pieces of research/ announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies…
- Rune Labs and Medtronic Partner to Evaluate Use of Medtronic BrainSense™ Data in Rune's Software for Precision Neurology - BioSpace November 2, 2021 Rune Labs and Medtronic Partner to Evaluate Use of Medtronic BrainSense™ Data in Rune's Software for Precision Neurology BioSpace
- Festival taps musician with Sandpoint ties for opening act July 1, 2021 By Ben Olson Reader Staff The main stage at the Festival at Sandpoint has hosted a who’s who of internationally acclaimed performers in its 38-year tenure. But, from time to …The post Festival taps musician with Sandpoint ties for opening act appeared first on Sandpoint Reader.
- Rune Labs Expands into Europe with Launch of Portuguese Subsidiary - PR Newswire May 19, 2022 Rune Labs Expands into Europe with Launch of Portuguese Subsidiary PR Newswire
- Rune Labs and Medtronic Partner to Evaluate Use of Medtronic BrainSense™ Data in Rune's Software for Precision Neurology - KPVI News 6 November 2, 2021 Rune Labs and Medtronic Partner to Evaluate Use of Medtronic BrainSense™ Data in Rune's Software for Precision Neurology KPVI News 6
- FDA Approves Smartwatch-Based Solution to Monitor Parkinson’s Disease - mHealthIntelligence.com June 15, 2022 FDA Approves Smartwatch-Based Solution to Monitor Parkinson’s Disease mHealthIntelligence.comStartup gets green light to use Apple Watch to track Parkinson's symptoms STATRune Labs' Apple Watch-based Parkinson's disease tracker gets FDA clearance The VergeRune Labs Secures FDA Clearance for Parkinson's Disease Monitoring through StrivePD Ecosystem on Apple Watch PR NewswireApple Watch Parkinson's monitoring app gets FDA clearance for clinical use 9to5Mac
- ASAP 2021 funding November 8, 2021 # # # # Aligning Science Across Parkinson’s represents a major new funder for Parkinson’s research. They are focused on basic biology research and require their grant holders to take a very collaborative, interdisciplinary, “open science” approach. In their first 2 years of funding, the organisation has awarded almost US$300 million in grants. That is kind of… how should…
- Bayer's BlueRock Therapeutics adjusts leadership team with CSO promoted to CEO - FierceBiotech July 26, 2021 Bayer's BlueRock Therapeutics adjusts leadership team with CSO promoted to CEO FierceBiotech
- Rune Labs carves out $22M for platform that translates brain data into neurological devices, drugs - FierceBiotech September 16, 2021 Rune Labs carves out $22M for platform that translates brain data into neurological devices, drugs FierceBiotech
- Monthly Research Review – January 2021 January 31, 2021 # # # # At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during the previous 4 weeks. The post is divided into eight parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical…
- Mo better for TEVA with Modag? October 27, 2021 # # # # This week the pharmaceutical company TEVA Pharmaceuticals Industries Ltd has announced a deal with a small German biotech firm called MODAG. The two companies are forming a strategic collaboration on the exclusive worldwide licensing and development of MODAG’s lead compound anle138b. Anle138b is a small molecule inhibitor of the believed to be toxic forms of…